CBD Life Sciences, Inc. (CBDL)
0.0002
0.00 (0.00%)
USD |
OTCM |
Oct 12, 16:00
CBD Life Sciences EPS Diluted (Quarterly) : 0.00 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -0.0001 |
| September 30, 2024 | -0.0005 |
| June 30, 2024 | -0.0001 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.003 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.003 |
| December 31, 2021 | -0.006 |
| September 30, 2021 | -0.018 |
| June 30, 2021 | -0.054 |
| March 31, 2021 | -0.063 |
| December 31, 2020 | -0.015 |
| September 30, 2020 | -0.402 |
| June 30, 2020 | -0.042 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.159 |
| September 30, 2019 | -0.303 |
| June 30, 2019 | -0.387 |
| March 31, 2019 | -1.653 |
| December 31, 2018 | -520.80 |
| September 30, 2018 | 49.50 |
| June 30, 2018 | -185.10 |
| March 31, 2018 | 150.00 |
| December 31, 2017 | 6000.00 |
| September 30, 2017 | -2550.00 |
| June 30, 2017 | -450.00 |
| March 31, 2017 | -3000.00 |
| December 31, 2016 | -1500.00 |
| September 30, 2016 | -1650.00 |
| June 30, 2016 | -2100.00 |
| March 31, 2016 | -1500.00 |
| December 31, 2015 | -1950.00 |
| September 30, 2015 | -1800.00 |
| June 30, 2015 | -2550.00 |
| March 31, 2015 | -1500.00 |
| December 31, 2014 | -5100.00 |
| September 30, 2014 | -182100.0 |
| June 30, 2014 | -68550.00 |
| March 31, 2014 | -75000.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ashland, Inc. | 0.3478 |
| Achieve Life Sciences, Inc. | -0.7996 |
| BioAdaptives, Inc. | 0.0106 |
| BellRing Brands, Inc. | 0.2933 |
| Aspire-Lakewood Holdings, Inc. | -1.222 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.0061M |
| Revenue (Quarterly) | 0.0132M |
| Total Expenses (Quarterly) | 0.0072M |
| Enterprise Value | 0.7424M |
| Gross Profit Margin (Quarterly) | 95.45% |
| Profit Margin (Quarterly) | 46.21% |